Peer-influenced content. Sources you trust. No registration required. This is HCN.

BloodDiagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel

Major advances in the understanding of acute myeloid leukemia (AML) has prompted the need for this update, which includes a revised European LeukemiaNet (ELN) genetic risk classification, revised response criteria, and treatment recommendations from the 2010 and 2017 editions.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form